Egrifta (Tesamorelin) and Acetaminophen Interaction
Clinical review of the tesamorelin and acetaminophen drug interaction, including hepatic metabolism overlap, CYP enzyme effects, monitoring recommendations, and dose guidance.
Read clinical reviewTopic Hub
Tesamorelin — Drug Interactions
19 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
19articles
121keywords mapped
2026-05-26latest review
Explore
Tesamorelin — Drug Interactions library
Showing 19 of 19 clinical reviews.
Egrifta (Tesamorelin) and Apixaban Interaction: Safety, Mechanism, and Clinical Guidance
Clinical review of the tesamorelin-apixaban drug interaction covering CYP3A4/P-gp mechanism, severity rating, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewEgrifta (Tesamorelin) and Benzodiazepines Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the tesamorelin, benzodiazepine drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for HIV-associated lipodystrophy.
Read clinical reviewEgrifta (Tesamorelin) and Bupropion Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the tesamorelin and bupropion drug interaction, covering mechanism, seizure risk, CYP2D6 considerations, monitoring protocols, and dose-adjustment strategies.
Read clinical reviewEgrifta (Tesamorelin) and Clopidogrel Interaction: What You Need to Know
Clinical analysis of the tesamorelin-clopidogrel drug interaction, covering CYP enzyme pathways, cardiovascular risk in HIV lipodystrophy, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewEgrifta (Tesamorelin) and Estradiol HRT Interaction: Safety, Risks, and Clinical Guidance
Can you take Egrifta (tesamorelin) with estradiol HRT? A physician-reviewed guide covering mechanism, severity, monitoring, dose adjustment, and patient counseling for this drug interaction.
Read clinical reviewEgrifta (Tesamorelin) and Levothyroxine Interaction: Safety, Monitoring, and Dose Adjustment
Clinical guide to the tesamorelin-levothyroxine interaction covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling with cited evidence.
Read clinical reviewEgrifta (Tesamorelin) and NSAIDs (Ibuprofen, Naproxen) Interaction
Clinical guide to combining tesamorelin (Egrifta) with NSAIDs like ibuprofen and naproxen. Covers pharmacokinetic and pharmacodynamic overlap, monitoring recommendations, and dose-adjustment considerations for patients with HIV-associated lipodystrophy.
Read clinical reviewEgrifta (Tesamorelin) and PPIs (Omeprazole, Pantoprazole): Drug Interaction Guide
A clinical deep-dive into the tesamorelin-PPI interaction: mechanism, severity, monitoring parameters, dose adjustments, and patient counseling backed by FDA labeling and primary literature.
Read clinical reviewEgrifta (Tesamorelin) and Prednisone Interaction: What Clinicians and Patients Should Know
A clinical review of the pharmacodynamic interaction between tesamorelin (Egrifta) and prednisone, covering glucose risk, body composition, bone effects, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewEgrifta (Tesamorelin) and Rivaroxaban Interaction: Safety, Risks, and Clinical Guidance
Can you take Egrifta (tesamorelin) with rivaroxaban? A physician-reviewed guide covering CYP3A4 mechanisms, severity ratings, monitoring protocols, and dose-adjustment considerations.
Read clinical reviewEgrifta (Tesamorelin) and Sildenafil Interaction: Safety, Mechanisms, and Clinical Guidance
Is it safe to take Egrifta (tesamorelin) with sildenafil? A physician-reviewed guide covering drug interaction mechanisms, monitoring requirements, dose adjustments, and clinical evidence for combining these medications.
Read clinical reviewEgrifta (Tesamorelin) and Simvastatin Interaction: What Patients and Clinicians Need to Know
A clinician-reviewed guide to the tesamorelin, simvastatin drug interaction, covering CYP3A4 mechanisms, rhabdomyolysis risk, IGF-1 monitoring, dose adjustment, and patient counseling for HIV-associated lipodystrophy.
Read clinical reviewEgrifta (Tesamorelin) and SNRIs (Venlafaxine, Duloxetine): Drug Interaction Guide
A clinician-level review of the tesamorelin, SNRI interaction covering mechanism, pharmacokinetics, serotonin-syndrome risk, blood-pressure effects, monitoring parameters, and patient counseling for safe co-administration.
Read clinical reviewEgrifta (Tesamorelin) and SSRIs (Sertraline, Escitalopram): Drug Interaction Guide
Can you take tesamorelin with SSRIs like sertraline or escitalopram? Review the pharmacokinetic and pharmacodynamic evidence, monitoring protocols, and clinical guidance for this combination.
Read clinical reviewEgrifta (Tesamorelin) and Tadalafil Interaction: Safety, Risks, and Clinical Guidance
Can you take Egrifta (tesamorelin) with tadalafil? A physician-reviewed guide covering pharmacokinetic and pharmacodynamic interactions, monitoring protocols, and dose-adjustment considerations.
Read clinical reviewEgrifta (Tesamorelin) and Testosterone Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the tesamorelin, testosterone drug interaction: mechanisms, polycythemia risk, lipid monitoring, dose considerations, and patient counseling backed by primary literature.
Read clinical reviewEgrifta (Tesamorelin) and Trazodone Interaction: Safety, Risks, and Clinical Guidance
Can you take tesamorelin (Egrifta) with trazodone? A physician-reviewed guide covering CYP metabolism, pharmacodynamic overlap, monitoring parameters, and dose-adjustment recommendations.
Read clinical reviewEgrifta (Tesamorelin) and Zolpidem Interaction: What Clinicians and Patients Should Know
A clinical review of the tesamorelin (Egrifta) and zolpidem drug interaction, covering pharmacokinetic and pharmacodynamic mechanisms, severity rating, monitoring parameters, dose adjustments, and patient counseling.
Read clinical review